ISIN | CH0114218610 |
---|---|
Valor Number | 11421861 |
Bloomberg Global ID | BBG0018SD0X6 |
Fund Name | Swiss Life iFunds (CH) Bond Global Corporates (CHF hedged) I-A 1 |
Fund Provider |
Swiss Life Asset Management AG
Zürich, Switzerland Phone: +41 44 284 77 09 E-Mail: info@swisslife-am.com Web: www.swisslife-am.com |
Fund Provider | Swiss Life Asset Management AG |
Representative in Switzerland | |
Distributor(s) |
Swiss Life AG Zürich Phone: +41 43 284 33 11 |
Asset Class | Bonds |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | Investment funds under Swiss law in the category "Other funds for traditional investments" - Investments in foreign currency debt securities of companies, including agencies and supranationals - A maximum of 10% government debt securities can also be included - Active bond selection, duration management and yield curve positioning - Debtor limitation: 10% (exception: if min. 8.3% representation in the benchmark, max. 120% of the benchmark weighting) - Average rating: at least BBB - Foreign currency risks will be at least 90% hedged against Swiss franc |
Peculiarities |
Current Price * | 792.26 CHF | 30.06.2025 |
---|---|---|
Previous Price * | 790.19 CHF | 27.06.2025 |
52 Week High * | 805.39 CHF | 16.09.2024 |
52 Week Low * | 770.76 CHF | 01.07.2024 |
NAV * | 792.26 CHF | 30.06.2025 |
Issue Price * | 794.16 CHF | 30.06.2025 |
Redemption Price * | 794.16 CHF | 30.06.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 686,783,071 | |
Unit/Share Assets *** | 609,249,607 | |
Trading Information SIX |
YTD Performance | +1.40% |
31.12.2024 - 30.06.2025
31.12.2024 30.06.2025 |
---|---|---|
1 month | +1.00% |
30.05.2025 - 30.06.2025
30.05.2025 30.06.2025 |
3 months | +0.55% |
31.03.2025 - 30.06.2025
31.03.2025 30.06.2025 |
6 months | +1.26% |
30.12.2024 - 30.06.2025
30.12.2024 30.06.2025 |
1 year | +2.79% |
01.07.2024 - 30.06.2025
01.07.2024 30.06.2025 |
2 years | +4.76% |
30.06.2023 - 30.06.2025
30.06.2023 30.06.2025 |
3 years | +1.89% |
30.06.2022 - 30.06.2025
30.06.2022 30.06.2025 |
5 years | -10.19% |
30.06.2020 - 30.06.2025
30.06.2020 30.06.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
GlaxoSmithKline Capital Inc. 4.875% | 1.00% | |
---|---|---|
PacifiCorp. 7.375% | 0.93% | |
Erste & Steiermarkische Bank Dionicko Drustvo 0.75% | 0.80% | |
Dell International L.L.C. and EMC Corporation 5.5% | 0.75% | |
DnB Bank ASA 5.896% | 0.72% | |
NatWest Group PLC 3.723% | 0.71% | |
American Medical Systems Europe B.V. 3% | 0.71% | |
JPMorgan Chase & Co. 5.294% | 0.70% | |
AES Corp. 5.8% | 0.70% | |
JPMorgan Chase & Co. 5.13518% | 0.68% | |
Last data update | 31.03.2025 |
TER | 0.15% |
---|---|
TER date | 30.09.2020 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.35% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 30.06.2025 |